🧾 What This Document Is

This is a Form 6-K from AMBEV S.A., filed with the U.S. Securities and Exchange Commission (SEC) for April 2026. Think of it as a standard monthly update from a foreign company listed in the U.S. This specific report has one job: to disclose stock transactions by company insiders from March 1st to March 31st, 2026. It's required by Brazilian and U.S. rules to keep the market informed about what the company's leaders are doing with their own shares.

👉 Why it matters: Watching insider transactions can be a clue about management's confidence. Are they buying, selling, or just holding? This report provides that data.

🏢 What The Company Does

AMBEV S.A. is a massive beverage company based in Brazil. 👉 In simple terms, they brew and sell beer! They are the powerhouse behind brands like Brahma, Antarctica, and Stella Artois in Latin America, and they also have a major non-alcoholic beverage business. They are a subsidiary of Anheuser-Busch InBev, the world's largest brewer.

👥 Insider Transactions Breakdown

This filing details trades by three separate groups of insiders. All transactions are in AMBEV's common shares or ADRs (American Depositary Receipts, which trade in the U.S.).

📋 Group 1: Board of Directors

• Starting Holdings: 30,400,903 common shares & 468,040 ADRs.
• Key Action: On March 6, the board received 298,839 restricted shares from the company at a price of R$15.29 per share. This was not an open-market purchase but a grant, likely as part of their compensation.
• Ending Holdings: 30,699,742 common shares & 468,040 ADRs.

⚙️ Group 2: Management (Executives)

This group had the most activity. Management includes top executives like the CEO and CFO.

• Starting Holdings: 4,585,877 common shares & 19,790 ADRs.
• Key Actions:
  • Received Restricted Shares: Like the board, executives received 606,656 restricted shares on March 6 at R$15.29 each.
  • Exercised Stock Options: They bought 466,169 shares by exercising options at a price of R$16.35.
  • Sold Shares: Throughout the month, executives sold shares multiple times through brokers like BTG Corretora and XP Corretora. The sales prices ranged from R$14.50 to R$15.14 per share. The largest single sale was 152,386 shares on March 27.
  • Renounced Shares: They gave up rights to 667,633 shares (likely forfeiting an award).
• Ending Holdings: 4,753,962 common shares & 19,790 ADRs.

🧪 Group 3: Technical & Consulting Committees

• Starting & Ending Holdings: 2,500 common shares.
• Key Action: No transactions were made by this group in March.

🚀 Key Moves & Why They Matter

• Restricted Share Grants (👍): The company awarded over 900,000 shares to its board and management. This aligns their interests with shareholders—they only profit if the stock price rises.
• Stock Option Exercise (📈): Executives used options to buy shares at R$16.35. This shows they saw value in converting their options into actual stock.
• Pattern of Sales (⚠️): Executives systematically sold shares after receiving grants and exercising options. This is common (to diversify personal wealth or pay taxes), but a consistent selling pattern can sometimes be a cautionary signal for investors to watch.

💸 Cash Flow Story

While this isn't a cash flow statement, we can see where cash moved. The company spent cash to deliver the restricted shares to insiders (a form of compensation). Insiders spent cash to exercise their options. Insiders then received cash from brokers when they sold their shares on the open market.

🔮 What's Next

This filing doesn't provide forward-looking guidance. The next key event for investors would be AMBEV's next quarterly earnings report or another material announcement. The activity in March sets the baseline for insider ownership going into the next quarter.

⚖️ Big Picture: Strengths & Risks

• 👍 Strength: The company uses equity compensation (restricted shares, options) to reward and align its leadership with long-term performance.
• ⚠️ Risk: Significant and repeated sales of shares by management, even if for planned reasons, can sometimes indicate a lack of strong conviction in the company's near-term prospects. It's a data point, not a definitive conclusion.

🧠 The Analogy

Think of this report as a mandatory diary page from the company's inner circle. It tells us they were handed new "company coupons" (restricted shares), cashed in some old "discount vouchers" (stock options), and then went shopping (sold shares) with the proceeds. It’s not necessarily bad—it’s normal financial management for them—but it shows us exactly what they did with their personal stakes.

🧩 Final Takeaway

AMBEV insiders received new shares and exercised options in March 2026, and several executives then sold a portion of their holdings. This is routine activity, but the selling pattern is worth noting as part of a broader analysis of insider sentiment.